|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2010-6-21
|
|
pubmed:abstractText |
The use of adjuvant chemoradiation for pancreatic adenocarcinoma (PAC) is accepted in North America, but there is a paucity of data to support this practice. The relation between adjuvant therapy and survival was assessed in a population-based cohort of patients with PAC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
116
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2932-40
|
|
pubmed:meshHeading |
pubmed-meshheading:20336787-Adenocarcinoma,
pubmed-meshheading:20336787-Aged,
pubmed-meshheading:20336787-Antineoplastic Agents,
pubmed-meshheading:20336787-Chemotherapy, Adjuvant,
pubmed-meshheading:20336787-Combined Modality Therapy,
pubmed-meshheading:20336787-Female,
pubmed-meshheading:20336787-Humans,
pubmed-meshheading:20336787-Male,
pubmed-meshheading:20336787-Middle Aged,
pubmed-meshheading:20336787-Pancreatic Neoplasms,
pubmed-meshheading:20336787-Radiotherapy, Adjuvant,
pubmed-meshheading:20336787-Survival Rate
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Adjuvant therapy and survival after resection of pancreatic adenocarcinoma: a population-based analysis.
|
|
pubmed:affiliation |
Department of Surgery, The Johns Hopkins Hospital, Baltimore, MD, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
